Critical Insights From Veru Analyst Ratings: What You Need To Know - Veru (NASDAQ:VERU)
Source: benzinga.com
📰 Internal Condom News
Internal Condom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Internal Condom. Real-time updates on events, politics, business and more.
Veru to Present at the GLP-1 Based Therapeutics Summit
MIAMI, FL, May 02, 2024 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and...
Source: marketscreener.com
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
MIAMI, FL, April 25, 2024 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and...
United States Samuel Fisch Globenewswire Inc Company Form American Association Of Clinical Endocrinology Corporate Communications
Source: marketscreener.com
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innova...
Source: businessinsider.com
Veru Announces Notification from Nasdaq Related to Delayed
MIAMI, FL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative...
Source: globenewswire.com
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
MIAMI, FL, Feb. 27, 2024 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, oncology,...
Source: marketscreener.com
Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs
FDA IND clearance is an important development milestone in advancing enobosarm in combination with GLP-1 drugs for potentially higher quality weight loss than has been shown with GLP-1 drug alone ...
Source: marketscreener.com
Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescription Revenues
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescription Revenues Veru Inc.May 12, 2021 GMT -- First Patient to Be Enrolled this Week in Phase 3 Clinical Trial of Sabizabulin (VERU-111) in High Risk Hospitalized COVID-19 Patients-- --New Drug Application Accepted for Review by FDA for Proprietary TADFIN Daily Oral Dosing Combination for BPH; PDUFA Date December 2021--...
United States Mitchell Steiner Sam Fisch Company Sexual Health Business Sexual Health Company Anticipates Enrolling First Patient In Phase
Source: apnews.com